Personalized health tech promises fall short for chronic condition patients
By
Victoria Song
Fresh out the oven, still warm. Top of the tray.
Summary
This article is a personal narrative from a Verge senior reviewer discussing the gap between the promises of personalized health technology and the reality for people with chronic conditions. The author shares her experience with hirsutism (excessive facial hair growth) as a symptom of an underlying chronic condition, and critiques how health tech companies market personalized solutions that fail to account for complex medical realities. The piece explores the pitfalls of algorithm-driven health recommendations that don't consider individual chronic conditions, while acknowledging the potential benefits of truly personalized health approaches.
Key quotes
· 3 pulledHirsutism is perhaps one of the few visual indicators of a condition that's plagued me for the past decade.
The reality is algorithms and features don't really take chronic conditions into account.
Health tech companies are chasing personalized health, but the reality is algorithms and features don't really take chronic conditions into account.
You might also wanna read
GE HealthCare Unveils AI and Radiopharmaceutical Innovations to Expand Nuclear Medicine Access at SNMMI 2026
GE HealthCare is showcasing new AI-enabled workflows, radiopharmaceuticals, and imaging innovations at the 2026 SNMMI Annual Meeting to help
Blockchain offers a path to patient-controlled wellness data beyond traditional EHR systems
The article discusses how traditional electronic health record (EHR) systems prioritize billing and institutional workflows over patient con
From Promise to Practice: The Challenges of Implementing AI in Medical Imaging
The article discusses the evolution and current state of AI in medical imaging, tracing progress from the 2012 AlexNet breakthrough to wides
Why Checking Your Phone First Thing in the Morning Harms Focus and Mood
This article examines the negative effects of reaching for your phone immediately upon waking. Mental health experts explain that the first
flip.it·3h agoPhase III trial finds EpiWatch smartwatch app detects tonic-clonic seizures with 98% accuracy
A Phase III clinical trial of the FDA-cleared EpiWatch smartwatch app demonstrated 98% accuracy in detecting tonic-clonic seizures in childr
Google's Debug program seeks EPA approval to release 64 million modified mosquitoes in California and Florida
Google's Debug program plans to release up to 64 million genetically modified "good" mosquitoes in California and Florida over two years to
